Conestoga Capital Advisors LLC Has $2.04 Million Holdings in Alpha Teknova, Inc. (NASDAQ:TKNO)

Conestoga Capital Advisors LLC cut its position in shares of Alpha Teknova, Inc. (NASDAQ:TKNO) by 19.9% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 244,344 shares of the company’s stock after selling 60,785 shares during the quarter. Conestoga Capital Advisors LLC owned 0.46% of Alpha Teknova worth $2,040,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. China Universal Asset Management Co. Ltd. acquired a new stake in Alpha Teknova during the fourth quarter valued at approximately $94,000. Whalen Wealth Management Inc. bought a new stake in shares of Alpha Teknova in the 4th quarter worth about $240,000. State Street Corp increased its position in shares of Alpha Teknova by 249.3% during the 3rd quarter. State Street Corp now owns 76,645 shares of the company’s stock worth $371,000 after purchasing an additional 54,700 shares in the last quarter. Geode Capital Management LLC boosted its position in Alpha Teknova by 24.4% in the third quarter. Geode Capital Management LLC now owns 188,173 shares of the company’s stock valued at $911,000 after buying an additional 36,914 shares in the last quarter. Finally, Point72 Asset Management L.P. bought a new stake in Alpha Teknova during the third quarter worth about $1,483,000. 13.81% of the stock is currently owned by institutional investors.

Alpha Teknova Stock Down 9.6 %

Shares of TKNO opened at $8.59 on Monday. The company has a market capitalization of $457.67 million, a P/E ratio of -11.61 and a beta of 0.34. Alpha Teknova, Inc. has a one year low of $1.15 and a one year high of $10.37. The business’s 50 day simple moving average is $8.23 and its 200-day simple moving average is $6.21. The company has a debt-to-equity ratio of 0.12, a current ratio of 4.73 and a quick ratio of 3.94.

Alpha Teknova (NASDAQ:TKNO) last announced its earnings results on Thursday, November 7th. The company reported ($0.15) EPS for the quarter, missing the consensus estimate of ($0.11) by ($0.04). Alpha Teknova had a negative return on equity of 35.30% and a negative net margin of 87.17%. The business had revenue of $9.58 million for the quarter, compared to the consensus estimate of $9.30 million. During the same quarter in the previous year, the company posted ($0.34) EPS. As a group, sell-side analysts predict that Alpha Teknova, Inc. will post -0.58 EPS for the current fiscal year.

Alpha Teknova Profile

Alpha Teknova, Inc produces critical reagents for the research, discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics in the United States and internationally. The company offers pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification.